To explore the role of the retina in diagnosing and managing neurodegenerative disorders through advanced imaging technologies.
Key Findings:
Many neurodegenerative diseases show early signs in the retina before structural changes occur.
FLIO allows for functional imaging of retinal metabolism, providing insights into neurodegenerative diseases.
Mitochondrial dysfunction is central to various neurodegenerative diseases, and advanced imaging can help study these processes.
Interpretation:
The advancements in imaging technologies and the understanding of the retina's role in neurodegeneration are transforming diagnosis and treatment approaches in neuro-ophthalmology.
Limitations:
FLIO is still a research device and not yet widely available for clinical use.
Regulatory approval for new imaging technologies and biomarkers is required before they can be used in clinical practice.
Conclusion:
The integration of advanced imaging and translational research in neuro-ophthalmology holds promise for earlier diagnosis and personalized treatment of neurodegenerative diseases.
